Key facts
- This page summarizes Michael J. Deppe's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2026, 16:43.
Michael J. Deppe - 04 Mar 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP, Corp. Controller & CAO
- Issuer ticker
- DGX
- Reported as of
- 04 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2026, 16:43:41 UTC
- Prior SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for Michael J. Deppe
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael J. Deppe filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 06 Mar 2026.
Change
- Previous filing in this sequence was filed on 04 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001771759
Primary reporting owner
Deppe Michael J
- Relationship
- SVP, Corp. Controller & CAO
- Address
- 500 PLAZA DRIVE, SECAUCUS
- Signature
- Sean D. Mersten, Attorney in Fact for Michael J. Deppe
- Signature date
- 06 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Award
- Transaction value
- Shares
- +1,473
- Change %
- +4.3%
- Price
- $204.86*
- Shares after
- 35,946
- Date
- 04 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -750
- Change %
- -2.1%
- Price
- $204.86*
- Shares after
- 35,196
- Date
- 04 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
Footnote F2
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.